share_log

HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target

HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target

HC Wainwright & Co.重申买入Aadi Bioscience,维持45美元的目标股价
Benzinga ·  2023/05/17 10:11

HC Wainwright & Co. analyst Robert Burns reiterates Aadi Bioscience (NASDAQ:AADI) with a Buy and maintains $45 price target.

HC Wainwright & Co. 分析师罗伯特·伯恩斯重申Aadi Bioscience(纳斯达克股票代码:AADI)的买入并维持45美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发